About Moonwalk Biosciences
Moonwalk Biosciences is a private company based in South San Francisco, California, incorporated in 2022 in Delaware. It has reported $109,574,981 raised in two offerings on Form D since January 2024.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 26, 2026 | Sep 14, 2026 | $59,999,998of $70.2M target | 7 | $8.5M | EquityRule 506(b) | Form D ↗ |
| Dec 18, 2023 | Jan 2, 2024 | $49,574,983of $56.8M target | 24 | $2.0M | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $109,574,981 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Moonwalk Biosciences's Form D filed Sep 14, 2026.
Chris Dimitropoulos
Managing Director, Alpha Wave Global
Also a director at Alto Neuroscience, Apnimed and Biolinq.
AJ
AA
SD
PB
Paul Burton
Director
EC